Prostate Cancer - Results from #26060

Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations - Abstract May 29, 2012

Androgen deprivation therapy in prostate cancer. Indication and systemic consequences - Abstract May 29, 2012

Patterns of prostate-specific antigen (PSA) testing in Australian men: The influence of family history - Abstract May 29, 2012

Cancer overdiagnosis and overtreatment - Abstract May 29, 2012

The role of 5-alpha-reductase inhibitors in active surveillance - Abstract May 29, 2012

Prostate cancer epidemiology in the United States - Abstract May 29, 2012

Q Fever masquerading as prostate cancer metastases - Abstract May 28, 2012

Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings - Abstract May 28, 2012

Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer - Abstract May 28, 2012

Health economics evaluation of magnetic resonance imaging for the staging of prostate cancer for Austria and Germany - Abstract May 28, 2012

Novel agents for the management of castration-resistant prostate cancer - Abstract May 28, 2012

Overcoming castration resistance in prostate cancer - Abstract May 28, 2012

Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer - Abstract May 28, 2012

Prostate-specific antigen levels in men aged 70 years and over: Findings from the CHAMP study - Abstract May 28, 2012

Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia - Abstract May 28, 2012

Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool - Abstract May 25, 2012

RNASEL study of genetics of prostate cancer and its relation to clinical staging - Abstract May 25, 2012

3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy - Abstract May 25, 2012

MRI in addition to or as a substitute for prostate biopsy: The clinician's point of view - Abstract May 25, 2012

Clinical significance of free-to-total prostate-specific antigen (PSA) ratio in advanced prostate cancer patients with PSA less than 0.1 ng/ml after hormone treatment - Abstract May 25, 2012

Page 1304 of 1451